Parma

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer1 trial
• Lung cancer1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals3 trials

Running trials

• Active, not recruiting

  Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera

  NCT05548062· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

  NCT01828099· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

  NCT00680901· Phase 3· Novartis Pharmaceuticals· Source